Chest, Vol 99, 1103-1107, Copyright © 1991 by American College of Chest Physicians

ARTICLES

Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy

K Shimokata, H Saka, T Murate, Y Hasegawa and T Hasegawa
First Department of Medicine, Nagoya University School of Medicine, Japan.

Tuberculous pleurisy is a good model for resolution of local cellular immunity. It would be expected that tuberculous pleural fluid contains a variety of immunologically important cytokines because of the accumulation of immunocompetent cells in the pleural cavity. We studied interleukin 1 (IL-1), interleukin 2 (IL-2), and interferon gamma (IFN- gamma) levels in pleural fluid of 20 patients with tuberculous pleurisy and compared them with those in pleural fluid of 20 patients with malignant pleurisy. We also evaluated adenosine deaminase (ADA) levels in both effusions. Tuberculous pleural fluid had higher levels of IL-1, IL-2, IFN-gamma, and ADA than malignant pleural fluid. Although the difference of IL-1 level between tuberculous and malignant pleural fluid was modest, that of IL-2, IFN-gamma, and ADA was dominant. These findings suggest that activated T lymphocytes in tuberculous pleural fluid concern the production of lymphokines at the morbid site and they effectively exert local cellular immunity through the action of such lymphokines.

This article has been cited by other articles:

				A. Gopi, S. M. Madhavan, S. K. Sharma, and S. A. Sahn Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006 Chest, March 1, 2007; 131(3): 880 - 889. [Abstract] [Full Text] [PDF]

				D. Atanackovic, A. Block, A. de Weerth, C. Faltz, D. K. Hossfeld, and S. Hegewisch-Becker Characterization of Effusion-Infiltrating T Cells: Benign versus Malignant Effusions Clin. Cancer Res., April 15, 2004; 10(8): 2600 - 2608. [Abstract] [Full Text] [PDF]

				K. Aoe, A. Hiraki, T. Murakami, R. Eda, T. Maeda, K. Sugi, and H. Takeyama Diagnostic Significance of Interferon-{gamma} in Tuberculous Pleural Effusions Chest, March 1, 2003; 123(3): 740 - 744. [Abstract] [Full Text] [PDF]

				K. Oshikawa, K. Yanagisawa, S. Ohno, S.-I. Tominaga, and Y. Sugiyama Expression of ST2 in Helper T Lymphocytes of Malignant Pleural Effusions Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 1005 - 1009. [Abstract] [Full Text] [PDF]

				N. Xirouchaki, N. Tzanakis, D. Bouros, D. Kyriakou, N. Karkavitsas, M. Alexandrakis, and N. M. Siafakas Diagnostic Value of Interleukin-1{alpha}, Interleukin-6, and Tumor Necrosis Factor in Pleural Effusions Chest, March 1, 2002; 121(3): 815 - 820. [Abstract] [Full Text] [PDF]

				K Takahashi, S Saito, Y Kamamura, M Katakawa, and Y Monden Prognostic value of CD4+ lymphocytes in pleural cavity of patients with non-small cell lung cancer Thorax, August 1, 2001; 56(8): 639 - 642. [Abstract] [Full Text] [PDF]

				N. P. JUFFERMANS, A. VERBON, J. T. BELISLE, P. J. HILL, P. SPEELMAN, S. J. H. van DEVENTER, and T. van der POLL Mycobacterial Lipoarabinomannan Induces an Inflammatory Response in the Mouse Lung . A Role for Interleukin-1 Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 486 - 489. [Abstract] [Full Text] [PDF]

				N. Nasreen, K. A. Mohammed, G. Galffy, M. J. Ward, and V. B. Antony MCP-1 in pleural injury: CCR2 mediates haptotaxis of pleural mesothelial cells Am J Physiol Lung Cell Mol Physiol, March 1, 2000; 278(3): L591 - L598. [Abstract] [Full Text] [PDF]

				C.-C. Hua, L.-C. Chang, Y.-C. Chen, and S.-C. Chang Proinflammatory Cytokines and Fibrinolytic Enzymes in Tuberculous and Malignant Pleural Effusions Chest, November 1, 1999; 116(5): 1292 - 1296. [Abstract] [Full Text] [PDF]

				S. Wongtim, U. Silachamroon, K. Ruxrungtham, V. Udompanich, S. Limthongkul, P. Charoenlap, and C. Nuchprayoon Interferon gamma for diagnosing tuberculous pleural effusions Thorax, October 1, 1999; 54(10): 921 - 924. [Abstract] [Full Text]

				L. Valdes, D. Alvarez, E. San Jose, P. Penela, J. M. Valle, J. M. Garcia-Pazos, J. Suarez, and A. Pose Tuberculous Pleurisy: A Study of 254 Patients Arch Intern Med, October 12, 1998; 158(18): 2017 - 2021. [Abstract] [Full Text] [PDF]

				N. P. JUFFERMANS, A. VERBON, S. J. H. van DEVENTER, H. van DEUTEKOM, P. SPEELMAN, and T. van der POLL Tumor Necrosis Factor and Interleukin-1 Inhibitors as Markers of Disease Activity of Tuberculosis Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1328 - 1331. [Abstract] [Full Text] [PDF]

				C. MARIE, M.-R. LOSSER, C. FITTING, N. KERMARREC, D. PAYEN, and J.-M. CAVAILLON Cytokines and Soluble Cytokine Receptors in Pleural Effusions from Septic and Nonseptic Patients Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1515 - 1522. [Abstract] [Full Text]